Trial Profile
Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Dose Escalation Trial to Determine Safety and Development of Protective Efficacy After Exposure to Only Pre-erythrocytic Stages of Plasmodium Falciparum
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jun 2021
Price :
$35
*
At a glance
- Drugs Malaria vaccine live attenuated-Sanaria (Primary) ; Chloroquine diphosphate; Pyrimethamine
- Indications Malaria
- Focus Adverse reactions; Therapeutic Use
- 27 Jun 2019 Status changed from recruiting to completed.
- 15 Dec 2018 Planned End Date changed from 30 Jun 2019 to 31 Dec 2020.
- 15 Dec 2018 Planned primary completion date changed from 31 Dec 2018 to 30 Jun 2020.